发明名称 |
Preventing diseases in infants delivered via caesarean section |
摘要 |
The present invention provides the use of a composition comprising non-digestible oligosaccharide for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. |
申请公布号 |
US9107438(B2) |
申请公布日期 |
2015.08.18 |
申请号 |
US201314135171 |
申请日期 |
2013.12.19 |
申请人 |
N.V. NUTRICIA |
发明人 |
Schmitt Joachim;Stahl Bernd;Knol Jan |
分类号 |
A23L1/29;A23C9/123;A23C9/20;A23L1/03;A23L1/30;A23L1/308;A61K31/202;A61K31/702;A61K31/7068;A61K31/7072;A61K31/7076;A61K31/708;A61K31/732;A61K31/734;A61K35/745;A61K35/747;A61K35/74;A61K47/36 |
主分类号 |
A23L1/29 |
代理机构 |
Foley & Lardner, LLP |
代理人 |
Villacorta Gilberto M.;Talapatra Sunit;Foley & Lardner, LLP |
主权项 |
1. A method for treatment and/or prevention of atopic dermatitis, eczema, asthma, allergic rhinitis or allergic conjunctivitis, in infants delivered via caesarean section comprising administering within 3 months of birth to an infant in need thereof a composition comprising 0.5 to 75 g of non-digestible oligosaccharides per 100 g dry weight of the composition, wherein the non-digestible oligosaccharides comprise galacto-oligosaccharides having at least 50% of its saccharide units as galactose units. |
地址 |
Zoetermeer NL |